Drug Screening Market Overview: Key Factors and Influencers
The global Drug Screening Market, a critical segment within the healthcare diagnostics landscape, was valued at approximately USD 9.99 billion in 2024. It is forecasted to experience a robust growth trajectory, reaching an estimated valuation of USD 106.89 billion by 2037. This dramatic expansion corresponds to CAGR around 20% during the forecast period. The rapid growth reflects increasing adoption of drug screening technologies across multiple sectors worldwide, driven by rising healthcare awareness, regulatory mandates, and technological progress in diagnostic tools.
